Diabetes Management icon Diabetes Management Medications

Diabetes management medicines help control blood glucose through insulin sensitivity, insulin release, glucose absorption, or glucose loss in urine. This category is most useful when you compare how each class lowers glucose and what monitoring it needs.

Acarbose Tablets

Acarbose

25 · 50mg

Slows down how your body breaks down carbohydrates to keep blood sugar levels more stable after meals.

Actos

Pioglitazone

15 · 30mg

Designed to target elevated blood sugar, indicated to alleviate insulin resistance and support better glucose control in type 2 diabetes.

Amaryl

Glimepiride

1 · 2 · 4mg

Formulated to support blood glucose control, intended to help manage type 2 diabetes by stimulating natural insulin production from the pancreas.

Farxiga

Dapagliflozin

5 · 10mg

developed to target type 2 diabetes mellitus to support healthy blood glucose levels.

Glucophage

Metformin

500 · 850 · 1000mg

Formulated to target type 2 diabetes mellitus to alleviate hyperglycemia through improved insulin sensitivity.

Glucophage Sr

Metformin

500mg

Indicated to manage blood glucose levels and formulated to support type 2 diabetes treatment.

Glucophage Xr

Metformin

1000mg

utilized to manage type 2 diabetes mellitus and indicated to support glucose control effectively for improved endocrine function.

Glucotrol

Glipizide

5 · 10mg

Indicated to address type 2 diabetes mellitus to mitigate high blood sugar levels.

Glucotrol Xl

Glipizide

5 · 10mg

indicated to manage blood sugar levels in type 2 diabetes mellitus and intended to support patients in maintaining glycaemic control.

Glucovance

Metformin, Glibenclamide

400/2.50 · 500/5mg

Designed to manage type 2 diabetes mellitus to support insulin sensitivity and blood glucose regulation.

Glycomet

Metformin

500mg

intended to target high blood sugar levels and to support metabolic control in diabetes.

Invokana

Canagliflozin

100mg

indicated to manage type 2 diabetes mellitus to support improved glycaemic control.

Januvia

Sitagliptin

50 · 100mg

Indicated to manage blood glucose levels in adults and formulated to support glycaemic control in type 2 diabetes.

Jentadueto

Linagliptin, Metformin

2.5/500mg

indicated to manage glycemic control in adults and developed to support blood glucose reduction in type 2 diabetes.

Metaglip

Glipizide, Metformin

2.5/500 · 5/500mg

Formulated to manage type 2 diabetes mellitus, this combined therapy is utilized to support blood glucose control and to mitigate glycemic fluctuations.

Metformin Tablets

Metformin

500 · 850 · 1000mg

Metformin Tablets are utilized to manage type 2 diabetes mellitus to alleviate hyperglycaemia, designed to support insulin sensitivity and to target blood glucose levels.

Micronase

Glyburide

2.5 · 5mg

Designed to target blood glucose levels utilized to support type 2 diabetes management.

Prandin

Repaglinide

0.5 · 1 · 2mg

This product is formulated for type 2 diabetes mellitus intended to mitigate glucose swings and support long-term metabolic control.

Precose

Acarbose

25 · 50mg

This medication is indicated to support blood sugar control and formulated to target post-prandial hyperglycaemia in type 2 diabetes mellitus.

Rybelsus

Semaglutide

3 · 7 · 14mg

Indicated to manage type 2 diabetes and developed to support blood sugar control and alleviate weight-related health risks in patients.

Semaglutide Tablets

Semaglutide

3 · 7 · 14mg

Formulated to manage type 2 diabetes mellitus and to support weight loss by mimicking natural hormones to regulate blood sugar and appetite levels.

Tradjenta

Linagliptin

5mg

utilized to manage type 2 diabetes mellitus to support glycaemic control.

Vsmall

Vildagliptin

50mg

Indicated for type 2 diabetes, utilized to target glycaemic levels and alleviate blood sugar imbalances to support long-term metabolic health.

What this category helps you sort out

Type 1 diabetes, type 2 diabetes, steroid-induced diabetes, and gestational diabetes are different clinical situations. Most medicines listed for this category are used in type 2 diabetes, but individual product indications matter.

Glucose treatment is not only about the reading today. Clinicians also consider HbA1c, kidney function, weight, heart disease, hypoglycaemia risk, pregnancy plans, and whether injections are acceptable.

How to compare options

  • Identify the class and mechanism: insulin sensitiser, insulin secretagogue, DPP-4 inhibitor, SGLT2 inhibitor, GLP-1 pathway medicine, or insulin.
  • Check hypoglycaemia risk, especially with insulin or sulfonylureas.
  • Review kidney function, dehydration risk, genital infection risk, and sick-day rules.
  • Look for weight effects, cardiovascular benefits, injection technique, and blood-glucose monitoring requirements.

Common medication groups

Biguanides and insulin sensitisers

Metformin is a common first-line medicine for type 2 diabetes because it improves insulin sensitivity and reduces liver glucose production. Gastrointestinal tolerability and kidney function are key checks.

Sulfonylureas and insulin-releasing medicines

These medicines encourage the pancreas to release more insulin. They can lower glucose effectively but carry a higher risk of low blood sugar and weight gain.

DPP-4 inhibitors, SGLT2 inhibitors, and newer options

These classes affect hormone signalling or glucose loss through urine. They are often compared by kidney suitability, weight effect, heart or kidney benefits, infection risk, and interactions.

Safety notes for this category

Low blood sugar, very high blood sugar, vomiting, dehydration, ketone symptoms, pregnancy, or acute illness can change diabetes medication safety quickly.

Never change diabetes medicines without a plan for monitoring glucose and knowing when to seek help.

Important Safety Information

Diabetes medicines differ in mechanism, hypoglycaemia risk, monitoring, and sick-day rules. This page is educational and does not replace diabetes review, blood tests, glucose monitoring advice, or product labeling.